
Unlocking the potential of synthetic DNA
Raquel Sanches-Kuiper, Vice President of Science and Applications at Evonetix, and Clare Whitewoods, Marketing Communications Manager at Evonetix, look at the benefits synthetic DNA brings to pharmaceutical development. Engineering biology is reshaping the world, from enabling the rapid development of vaccines to providing alternatives to petroleum fuels. The rapid progress… Read More














